Mirum Pharmaceuticals (MIRM) announced the appointment of Doug Sheehy as Chief Legal Officer. Sheehy was most recently Chief Legal Officer at Sonoma Biotherapeutics. He brings nearly two decades of experience leading global legal and compliance operations for biopharmaceutical companies.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MIRM:
- Mirum Pharmaceuticals assumed with a Buy at H.C. Wainwright
- Mirum Pharmaceuticals price target raised to $77 from $73 at Raymond James
- Buy Rating on Mirum Pharmaceuticals: Promising Phase 2b VANTAGE Study Results and Strong Market Potential
- Mirum’s volixibat shows ‘best-in-class potential,’ says Citi
- Mirum Pharmaceuticals price target raised to $76 from $74 at Citizens JMP